Skip to content
Home/Companies/MedTech/ZYTOMICS
ZY

ZYTOMICS

MedTech·Germany·Active·6yr hold

ZYTOMICS is a diagnostics company, headquartered in Germany.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns ZYTOMICS?

ZYTOMICS is currently owned by ARCHIMED through MED Platform I (2019 vintage), since 2020.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED Platform I · 2019 · Buyout

Key facts

HQGermany
SectorDiagnostics

More from MED Platform I

Other portfolio companies in the same fund.

CARSO
Active
MedTechFrance· 2021
Ad-Tech Medical Instrument
Exited 2024
MedTechUS· 2020
to
Ametris (ActiGraph)
Exited 2026
HealthTechUS· 2020
to
NAMSA
Active
MedTechUS· 2020
Bomi Group
Exited 2023
MedTechItaly· 2019
to
DIESSE
Exited 2025
MedTechItaly· 2019
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Serres
Active
G Square Healthcare PEFinland· 2026
Amoena
Active
Apera Asset ManagementGermany· 2025
Amotio
Active
Development Bank of WalesUK· 2025
APEX Digital
Active
Generis Capital PartnersFrance· 2025
Data refreshed weekly · Sourced from public filings